During the past decade, Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose" are "Allergic Alveolitis" (1 trials), "Children´s Interstitial Lung Disease" (1 trials), "Diffuse Parenchymal Lung Disease" (1 trials) and "Interstitial Lung Disease" (1 trials). Many other conditions were trialed in "Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Hydroxychloroquine sulfate" (1 trials) and "Prednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".